Ask about Ipamorelin

Get a grounded answer across clinical evidence, community patterns, and risks.

Ask AI →

Ipamorelin

GH/GHRH Research Compound

Growth hormone releasing peptide (GHRP)

Mechanism of Action

Stimulates ghrelin receptors to release growth hormone. Considered one of the mildest GHRPs with fewer side effects.

Ipamorelin is a research compound (not FDA-approved) that stimulates ghrelin receptors to promote growth hormone release. Self-reported data from 112 individuals across 253 reports suggests dominant areas of interest are body composition (40.2%) and sleep quality (24.1%) — outpacing direct GH elevation (21.4%) as a primary focus.

766
Community Posts
287
Users Discussing
2
Research Articles
1
Clinical Trials

Reported Outcomes

Clinical grade reflects published research; Community grade reflects user reports (n=766).

Growth Hormone

Effects on growth hormone levels

Clinical: D
Community: B
35% (195)
Body Composition

Changes in muscle vs fat ratio

Clinical: D
Community: B
33% (136)
Sleep Quality

Effects on sleep quality

Clinical: C
Community: B
32% (152)
Energy Levels

Changes in energy and fatigue levels

Clinical: D
Community: B
14% (48)
Mental/Mood

Effects on mood and cognitive function

Clinical: D
Community: A
10% (39)
Muscle Repair

Muscle recovery and repair from exercise or injury

Clinical: D
Community: B
2% (8)

Who Discusses Ipamorelin

From community reports with demographic data.

Gender

Male 85%
Female 15%

n=108

Age Distribution

45
median age
range: 26-64
<30
30s
40s
50s
60+

n=49

Side Effects

Limited data

Based on 11 user reports (n=11). Frequency indicates how often each was mentioned.

Uncommon (1-5%)

Drenching Night Sweats
Mild 1 reports 4.2%
Tingling Issue
Mild 1 reports 4.2%
Injection Site Reaction (Isr)
Mild 1 reports 4.2%
Pain
Mild 1 reports 4.2%
High Estrogen
Mild 1 reports 4.2%
Post Injection Pain (Pip)
Mild 1 reports 4.2%
Bump And Redness At Injection Site
Mild 1 reports 4.2%

Risks & Warnings

Important safety considerations based on clinical data and community reports.

!

Carpal Tunnel

11 mentions

May occur with elevated GH levels. Usually resolves with dose adjustment.

!

Psychiatric Effects

4 mentions

Monitor for mood changes. Report any concerning psychiatric symptoms to healthcare provider.

i

Water Retention

34 mentions

Fluid retention can occur with GH-releasing peptides. Usually mild and temporary.

i

Injection Site Reactions

21 mentions

Local reactions are common and usually mild. Rotate injection sites.

Dosing

Standard Protocol

Starting Dose
100-300mcg 2-3x daily
Titration
No established protocol
Half-life
~2 hours
Administration
Subcutaneous injection

Community Dosing Patterns

Based on 142 mentions

Community-reported patterns, not medical advice.

250mcg daily
15
daily
11
200mcg daily
7
300mcg daily
5
150mcg daily
4

Pricing

Research-grade reference pricing for 10mg vial. Prices vary by vendor and quantity. Research chemicals require self-mixing and lack medical oversight. Shipping is not included.

We do not list vendors. Prices are aggregated from community reports and should be treated as rough ranges.

US Research Grade

$70

Single small vial from US domestic vendors

US Research (Bulk)

$39.2

Per-dose equivalent when buying larger US vials

China Research

$6

Per-vial when buying 10-pack from Chinese vendors

Research

2
Total Articles
1
Clinical Trials
1
Reviews

Key Studies

Commonly Stacked With

From community members' documented stacks involving Ipamorelin.

CJC-1295 193 stacks (52.9%)
Tesamorelin 166 stacks (45.5%)
Retatrutide 122 stacks (33.4%)
Tirzepatide 72 stacks (19.7%)
BPC-157 41 stacks (11.2%)

Switching Patterns

Based on 88 discussions about switching to or from Ipamorelin.

Switching FROM

Retatrutide 19 mentions
Tesamorelin 13 mentions
CJC-1295 6 mentions
Tirzepatide 5 mentions

Users who switched to Ipamorelin

Switching TO

Retatrutide 15 mentions
Tesamorelin 11 mentions
CJC-1295 8 mentions
GHK-Cu 6 mentions

Users who switched from Ipamorelin